🇨🇦 Ro 205720 in Canada

Ro 205720 (CARPROFEN) regulatory status in Canada.

Marketing authorisation

Ro 205720 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Pain approved in Canada

Frequently asked questions

Is Ro 205720 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Ro 205720 in Canada?

Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.